Letco Medical considers patient safety as a top priority and supports the FDA's warning regarding the inappropriate use of glutathione powder in sterile injectable compound formulations



[ad_1]

WAYNE, Pa., February 1, 2019 / PRNewswire / – On February 1, 2019, the Federal Food and Drug Administration (FDA) issued a statement warning manufacturers "not to use glutathione-L-reduced powder dispensed by Letco Medical", Decatur, Alabama, Letco Medical considers that patient safety is a top priority and therefore welcomes the FDA's warning regarding the inappropriate use of ingredients labeled as dietary supplements, such as L-glutathione by preparers in sterile formulations. L- Glutathione and all food supplement quality ingredients sold by Letco Medical are clearly marked "Attention: dietary supplement". When they are used as stated on the label in accordance with 21 USC § 321, food supplements sold by Letco Medical are safe.

Letco Med (PRNewsfoto / Letco Medical, L.L.C.)

We have been informed of the FDA statement and believe that it is the result of a case in which a pharmacy pharmacy had misused the ingredient of Letco Medical's complementary quality L-Glutathione. in a sterile injectable drug product, unlike its labeled use, and released and dispensed drug without testing it. As all the composing professionals know, the ingredients in the composition titled "Caution: Food Supplement" are not suitable for the production of sterile medicinal products, regardless of the manufacturer, the supplier or the batch number. We would like to take this opportunity to reiterate this requirement on the market.

If you have questions or concerns about the proper use of Letco's dietary supplements or product labels, please contact us at 877-538-2679.

About Letco Medical, L.L.C.

Letco Medical, L.L.C. ("Letco Med"), a company wholly owned by employees and headquartered in Wayne, PA, is the partner of choice for profit-oriented drug preparation pharmacies around the world. Letco Med has invested heavily in creating a company capable of meeting the needs of pharmacists preparing for today, tomorrow and the future, with a full range of products as well as programs and programs. Additional services. Particularly focused on the US compositional market, Letco Med offers a broad and comprehensive portfolio of high quality, safe and consistent chemicals, supplies and equipment at very competitive prices. The Letco Med product line includes chemicals covering a wide range of therapeutic categories, as well as supplies, equipment, capsules, prefabricated topical bases and oral delivery vectors. In addition, Letco Med offers a broad badortment of dosage forms and administration systems.

Since its inception in 1993, Letco Med has forged a reputation as one of the most innovative companies in the composition industry. Letco Med focuses on unshakable quality, exemplified by the quality badurance programs and rigorous quality control procedures of the industry.

For more information, visit www.letcomed.com.

Cision "src =" https://c212.net/c/img/favicon.png?sn=PH42115&sd=2019-02-01 View the original content to download the multimedia: https: //www.prnewswire.com/news-releases/letco-medical-considers-patient-safety-its-highest-priority-and-supports-the-fdas-warning-warning -waring-concerning-the-appropriate-use-of-glutathione powder in compound sterile injectable formulations-300788537.html

SOURCE Letco Medical

[ad_2]
Source link